IGC Pharma, Inc. (IGC): Total Liabilities
$2.42M
As of 2025-03-31
-6.3%
3-year compound annual growth
-0.2%
5-year compound annual growth
-8.0%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-03-31 | $2.42M | -6.4% | 2025-06-27, Balance as of period end |
| 2024-03-31 | $2.58M | +13.9% | 2025-06-27, Balance as of period end |
| 2023-03-31 | $2.27M | -22.9% | 2024-06-24, Balance as of period end |
| 2022-03-31 | $2.94M | -4.0% | 2023-07-07, Balance as of period end |
| 2021-03-31 | $3.06M | +25.2% | 2022-06-23, Balance as of period end |
| 2020-03-31 | $2.45M | +174.0% | 2021-06-14, Balance as of period end |
| 2019-03-31 | $893.0K | -68.0% | 2020-07-13, Balance as of period end |
| 2018-03-31 | $2.79M | -29.1% | 2019-06-14, Balance as of period end |
| 2017-03-31 | $3.93M | -19.9% | 2018-06-21, Balance as of period end |
| 2016-03-31 | $4.91M | -12.0% | 2017-07-14, Balance as of period end |
| 2015-03-31 | $5.58M | +55.5% | 2016-07-14, Balance as of period end |
| 2014-03-31 | $3.59M | -16.1% | 2015-07-14, Balance as of period end |
| 2013-03-31 | $4.28M | -54.7% | 2014-07-15, Balance as of period end |
| 2012-03-31 | $9.44M | +21.3% | 2014-07-15, Balance as of period end |
| 2011-03-31 | $7.79M | n/a | 2012-07-16, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| IGC Pharma, Inc. (IGC) | 2025-03-31 | $2.42M | -6.4% |
| Vistagen Therapeutics, Inc. (VTGN) | 2026-03-31 | $13.04M | -6.5% |
| Longeveron Inc. (LGVN) | 2025-12-31 | $4.59M | +24.9% |
| Cannapharmarx, Inc. (CPMD) | 2025-12-31 | $37.17M | +21.3% |
| Neuphoria Therapeutics Inc. (NEUP) | 2026-06-30 | $4.11M | -57.1% |
| Northwest Biotherapeutics Inc (NWBO) | 2025-12-31 | $128.86M | +21.9% |
| Avenue Therapeutics, Inc. (ATXI) | 2025-12-31 | $1.10M | +34.7% |
| China SXT Pharmaceuticals, Inc. (SXTC) | 2026-03-31 | $5.05M | -18.9% |
| NRX Pharmaceuticals, Inc. (NRXP) | 2025-12-31 | $28.89M | +7.5% |
Compare IGC, VTGN, LGVN, CPMD side by side · Screen every company in Pharmaceutical Preparations ↗